Kenneth M Snader

This inventor holds 16 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Smithkline Corporation, Smithkline Beckman Corporation. Active years: 1976-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth M Snader. Retrieved from https://idiyas.com/inventor/kenneth-m-snader

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16

% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 49(Granted Patents)

Company Filing History:

13 out of 344

Smithkline Corporation

patents

3 out of 207

Smithkline Beckman Corporation

patents

Years Active: 1976-1988

Loading Chart...

Areas of Expertise:

Affinity Chromatography

Vancomycin

Anthracycline Antibiotics

Imidodisulfamides

2H-Pyran Derivatives

Asthma Treatment

Pharmaceutical Compositions

Cinnamoyl Derivatives

Aurones

Streptosporangium

Purification Processes

Antiallergic Compounds

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4778846 - Affinity chromatography sorbent (1988-10-18),

2. 4667024 - Process for the preparation of purified vancomycin class antibiotics (1987-05-19),

3. 4385122 - Anthracycline antibiotics produced by streptosporangium fragile (1983-05-24),

4. 4293546 - Anthracycline antibiotics produced by Streptosporangium fragilis Shearer (1981-10-06),

5. 4292305 - Antiallergic imidodisulfamides (1981-09-29),

6. 4165365 - Substituted 2H-pyran-2,6(3H)-dione derivatives (1979-08-21),

7. 4160021 - Substituted 2H-pyran-2,6(3H)-dione derivatives (1979-07-03),

8. 4127646 - Substituted 2H-pyran-2,6(3H)-dione derivatives (1978-11-28),

9. 4122201 - Method of treating asthma with 4,6-dihydroxy-2H-pyran-2-ones (1978-10-24),

10. 4117226 - Substituted 3-cinnamoyl-2H-pyran-2,6(3H)-diones (1978-09-26),

11. 4083952 - Substituted aurones (1978-04-11),

12. 4032652 - Substituted 2H-pyran-2,6(3H)-dione derivatives, pharmaceutical (1977-06-28),

13. 4025642 - Substituted 2H-pyran-2, 6(3H)-dione derivatives (1977-05-24),

14. 4025614 - Substituted 2H-pyran-2,6 (3H)-dione derivatives useful in treatment of (1977-05-24),

15. 4015009 - Pharmaceutical compositions comprising substituted (1977-03-29),

Title: Discovering the Innovations of Kenneth M. Snader

Introduction

Kenneth M. Snader is a notable inventor based in Hatboro, Pennsylvania, with an impressive portfolio that includes 16 patents. His contributions to the field of pharmaceutical sciences focus on innovative processes for the isolation and purification of vancomycin class antibiotics. His work has significantly impacted the way these crucial antibiotics are developed and used in medical treatments.

Latest Patents

Among his latest patents, Snader has developed an affinity chromatography sorbent and a process for the preparation of purified vancomycin class antibiotics. Both patents utilize a novel process involving affinity chromatography through the formation of a sorption complex between the antibiotic and an immobilizing ligand derived from -D-alanyl-D-alanine or -X-D-alanyl-D-alanine, where X represents an amino acid radical. The innovative affinity chromatography sorbent disclosed in these patents serves as a vital tool for enhancing the efficiency and effectiveness of antibiotic purification.

Career Highlights

Kenneth Snader's professional journey includes significant roles at renowned companies such as SmithKline Corporation and SmithKline Beecham Corporation. His career reflects a strong commitment to advancing pharmaceutical research and the development of antibiotic treatments, showcasing his dedication to improving public health.

Collaborations

Throughout his career, Snader has collaborated with notable professionals, including Chester Rhodes Willis and Chester R. Willis. These partnerships have fueled his research endeavors and contributed to the successful completion of several innovative projects in the field of antibiotic development.

Conclusion

Kenneth M. Snader exemplifies the impact that a dedicated inventor can have on the field of pharmaceuticals. His numerous patents and collaborative efforts with esteemed colleagues highlight a relentless pursuit of innovation aimed at improving the purification of vancomycin class antibiotics. As the field continues to evolve, Snader's contributions will undoubtedly play a crucial role in the ongoing battle against bacterial infections.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]